Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase

被引:13
|
作者
Kratky, Martin [1 ]
Stepankova, Sarka [2 ]
Vorcakova, Katarina [2 ]
Vinsova, Jarmila [1 ]
机构
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Organ & Bioorgan Chem, Akad Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
[2] Univ Pardubice, Dept Biol & Biochem Sci, Fac Chem Technol, Studentska 573, Pardubice 53210, Czech Republic
关键词
Acetylcholinesterase; Butyrylcholinesterase; Carbamate; Enzyme inhibition; In vitro inhibition; Salicylanilide; IN-VITRO EVALUATION; CHOLINESTERASE-INHIBITORS; ACETYLCHOLINESTERASE INHIBITORS; HYDROLYZE ACETYLCHOLINE; ALZHEIMERS-DISEASE; NEUROPROTECTION; DERIVATIVES; BRAIN;
D O I
10.1016/j.bioorg.2018.07.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on the presence of carbamate moiety, twenty salicylanilide N-monosubstituted carbamates concomitantly with their parent salicylanilides and five newly prepared 4-chlorophenyl carbamates obtained from isocyanates were investigated using Ellman's method for their in vitro inhibitory activity against acetylcholinesterase (AChE) from electric eel and butyrylcholinesterase (BChE) from equine serum. The carbamates and salicylanilides exhibited mostly a moderate inhibition of both cholinesterase enzymes with IC(50 )values ranging from 5 to 235 mu M. IC(50 )values for AChE were in a narrower concentration range when compared to BChE, but many of the compounds produced a balanced inhibition of both cholinesterases. The derivatives were comparable or superior to rivastigmine for AChE inhibition, but only a few of carbamates also for BChE. Several structure-activity relationships were identified, e.g., N-phenethylcarbamates produce clearly favourable BChE inhibition. The compounds also share convenient physicochemical properties for CNS penetration.
引用
收藏
页码:668 / 673
页数:6
相关论文
共 4 条
  • [1] Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors
    Horakova, Eva
    Drabina, Pavel
    Broz, Bretislav
    Stepankova, Sarka
    Vorcakova, Katarina
    Kralovec, Karel
    Havelek, Radim
    Sedlak, Milos
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 : 173 - 179
  • [2] Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl-Pyridazine Moiety for the Potential Treatment of Alzheimer's Disease
    Elsawalhy, Mohamed
    Abdel-Rahman, Adel A-H
    Basiony, Ebtesam A.
    Ellithy, Salma A.
    Hassan, Allam A.
    Abou-Amra, Eman S.
    Ismail, Abdelhamid
    Almehizia, Abdulrahman A.
    Al-Omar, Mohamed A.
    Naglah, Ahmed M.
    Hassan, Nasser A.
    PHARMACEUTICALS, 2024, 17 (10)
  • [3] New Hybrids of 4-Amino-2,3-polymethylene-quinoline andp-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment
    Makhaeva, Galina F.
    Kovaleva, Nadezhda, V
    Boltneva, Natalia P.
    Lushchekina, Sofya, V
    Astakhova, Tatiana Yu
    Rudakova, Elena, V
    Proshin, Alexey N.
    Serkov, Igor, V
    Radchenko, Eugene, V
    Palyulin, Vladimir A.
    Bachurin, Sergey O.
    Richardson, Rudy J.
    MOLECULES, 2020, 25 (17):
  • [4] 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields
    Vitorovic-Todorovic, Maja D.
    Juranic, Ivan O.
    Mandic, Ljuba M.
    Drakulic, Branko J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (03) : 1181 - 1193